Study Abstract Recognized as Best Clinical Abstract at 2022 Radiosurgical Society Meeting SUNNYVALE, Calif. , March 31, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed 72
CARTI is First in Arkansas to Treat Patients with World's Only Robotic Radiosurgery System SUNNYVALE, Calif. , March 8, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the state
Robotic Radiosurgery System Provides Effective, Non-invasive Treatment Option for this Chronic Pain Condition, Typically Delivered in Just One Out-Patient Procedure SUNNYVALE, Calif. , Feb. 28, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the National Institute for
Company to Take Part in Fireside Chat Monday, March 7, 2022 at 9:50am PST / 12:50pm EST SUNNYVALE, Calif. , Feb. 24, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 42nd Annual Health Care Conference taking place March 7-9, 2022 .
- Royal Brisbane and Women's Hospital acquisition is intended to expand access to potentially life-saving radiotherapy treatments to more patients - Hospital was the first in Australia to invest in the TomoTherapy® helical radiotherapy delivery platform and is now the first to secure the latest
- Phase III, randomized controlled trial results highlight patient reported outcomes at 10 years'follow-up - TomoTherapy delivered hypofractionated radiotherapy was superior to conventional radiotherapy in maintaining patients' heart and lung functioning, enabling them to more easily perform daily
SUNNYVALE, Calif. , Feb. 7, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the virtual BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference , which takes place February 15-17, 2022 .
Record Revenue For Second Quarter Fiscal 2022 SUNNYVALE, Calif. , Jan. 26, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2022 ended December 31, 2021 . Second Quarter Fiscal 2022 Summary Record net revenue of $116.3
SUNNYVALE, Calif. , Jan. 12, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2022, ended December 31, 2021, after the market close on Wednesday, January 26, 2022. Management will host a conference call to review the
- Trigeminal neuralgia, a persistent neurological disorder, is described by some patients as the most excruciating pain human beings can experience(1) - The approval expands global patient access to the CyberKnife System, an effective, non-invasive treatment alternative to surgery SUNNYVALE, Calif.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
